New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
08:26 EDTESRX, WLPWellPoint price target raised to $130 from $120 at Leerink
Leerink believes WellPoint (WLP) has "strong negotiating leverage" against Express Scripts (ESRX) over the 10-year contract between the two companies. Leerink thinks the contract could be renewed early under more favorable rates for WellPoint. The firm raised its price target for shares to $130 and keeps an Outperform rating on the stock. Leerink also raised its price target for Express Scripts shares to $85 from $80.
News For WLP;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
16:39 EDTESRXBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
14:53 EDTESRXCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
08:04 EDTWLPWellPoint, Boehringer Ingelheim announce first project under collaboration
Boehringer Ingelheim Pharmaceuticals, WellPoint and HealthCore, announced that the companies are commencing a research project to identify and address unmet medical needs across populations of mutual interest. The first stage of the project will focus on non-valvular atrial fibrillation and will examine disease prevalence, treatment complications, such as hospital readmissions, and the use of evidence-based guidelines. This project is the first under the parties’ five-year research collaboration agreement, signed earlier this year. Information gathered through the NVAF project is intended to provide the basis for the collaborative development of healthcare interventions, which can be evaluated within WellPoint’s affiliated health plans and provider networks.
November 12, 2014
08:58 EDTWLPManaged Care earnings risk low from King vs. Burwell, says Leerink
Leerink believes the Supreme Court decision to the King vs. Burwell case carries low earnings risk for Managed Care companies. The case to determine the legality of Exchange subsidies administered by the Federal Government carries less than 2% and 3% of earnings risk for 2014 and 2015 estimates, respectively, Leerink believes. The firm says Humana (HUM) and Cigna (CI) are currently losing money on Exchanges, and thus could benefit from any Federal Exchange membership loss. Leerink lists Aetna (AET), Centene (CNC), WellPoint (WLP) and Molina Healthcare (MOH) as being most impacted.
November 11, 2014
12:55 EDTWLPWorkarounds to likely protect insurers from Supreme Court decision, says Wedbush
Subscribe for More Information
November 10, 2014
15:53 EDTWLPCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
07:34 EDTWLPWellPoint has strong momentum heading into 2015, says UBS
UBS said WellPoint has strong momentum across all business segments heading into 2015. The firm expects the company's national account business to grow and sees the company having earnings power from the public exchanges, Medicare, and Medicaid. UBS reiterates its Buy rating on WellPoint and raised its price target to $150 from $144.
November 7, 2014
14:14 EDTWLPACA subsidies look likely to be upheld, says UBS
After the Supreme Court agreed to hear a lawsuit challenging the government's right to pay ACA subsidies through the federal exchange, UBS says "it seems quite likely" that the subsidies will be upheld. The firm says that most experts expect a majority of justices to adopt the view that the law's intent was to expand coverage as widely as possible. Publicly traded hospital owners include Community Health (CYH), HCA Holdings (HCA), LifePoint Hospitals (LPNT), Tenet (THC) and Universal Health (UHS).Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use